Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Hepatocellular | 3 | 2025 | 163 | 1.190 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 224 | 1.140 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2025 | 6 | 0.960 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 67 | 0.960 |
Why?
|
| Osteopontin | 1 | 2025 | 46 | 0.930 |
Why?
|
| Hedgehog Proteins | 1 | 2025 | 54 | 0.910 |
Why?
|
| Activities of Daily Living | 1 | 2025 | 139 | 0.890 |
Why?
|
| Postoperative Complications | 1 | 2025 | 263 | 0.820 |
Why?
|
| Urban Renewal | 1 | 2023 | 2 | 0.800 |
Why?
|
| Environmental Monitoring | 2 | 2023 | 230 | 0.790 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 20 | 0.620 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 220 | 0.570 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2026 | 67 | 0.440 |
Why?
|
| Histones | 2 | 2025 | 197 | 0.410 |
Why?
|
| Pancreatic Neoplasms | 2 | 2026 | 218 | 0.380 |
Why?
|
| Calcium Channels | 3 | 2025 | 73 | 0.380 |
Why?
|
| Environment | 2 | 2024 | 149 | 0.370 |
Why?
|
| Calcium | 3 | 2025 | 491 | 0.340 |
Why?
|
| Stomach Neoplasms | 2 | 2024 | 241 | 0.320 |
Why?
|
| Mitochondria | 3 | 2024 | 523 | 0.290 |
Why?
|
| Mitochondria, Liver | 2 | 2025 | 15 | 0.280 |
Why?
|
| Cell Line, Tumor | 5 | 2026 | 2676 | 0.280 |
Why?
|
| Humans | 19 | 2026 | 43102 | 0.270 |
Why?
|
| Mice | 8 | 2026 | 6644 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2025 | 968 | 0.270 |
Why?
|
| Cities | 3 | 2023 | 79 | 0.260 |
Why?
|
| Hepatic Stellate Cells | 1 | 2025 | 7 | 0.240 |
Why?
|
| Sarcopenia | 1 | 2025 | 15 | 0.240 |
Why?
|
| Dendritic Cells | 1 | 2026 | 132 | 0.220 |
Why?
|
| Sirtuin 1 | 1 | 2024 | 34 | 0.220 |
Why?
|
| Choline Deficiency | 1 | 2024 | 4 | 0.220 |
Why?
|
| Mice, Nude | 1 | 2025 | 408 | 0.220 |
Why?
|
| Glycolysis | 1 | 2024 | 71 | 0.220 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2025 | 74 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 347 | 0.210 |
Why?
|
| Animals | 10 | 2026 | 16992 | 0.210 |
Why?
|
| Lactic Acid | 1 | 2025 | 112 | 0.210 |
Why?
|
| Fatty Liver | 1 | 2024 | 77 | 0.200 |
Why?
|
| T-Lymphocytes | 1 | 2026 | 386 | 0.200 |
Why?
|
| Conservation of Natural Resources | 1 | 2023 | 48 | 0.190 |
Why?
|
| Male | 8 | 2025 | 23409 | 0.190 |
Why?
|
| Age Factors | 1 | 2025 | 1154 | 0.190 |
Why?
|
| Food Supply | 1 | 2024 | 122 | 0.190 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 1596 | 0.180 |
Why?
|
| Cytokines | 1 | 2026 | 678 | 0.180 |
Why?
|
| Operating Rooms | 1 | 2021 | 5 | 0.180 |
Why?
|
| Female | 5 | 2025 | 24698 | 0.170 |
Why?
|
| RNA, Messenger | 1 | 2026 | 1271 | 0.170 |
Why?
|
| Hepatitis A | 1 | 2020 | 11 | 0.170 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 133 | 0.170 |
Why?
|
| Aged | 2 | 2025 | 8214 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 23 | 0.160 |
Why?
|
| Fluorouracil | 1 | 2020 | 47 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2025 | 2157 | 0.150 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1081 | 0.150 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 175 | 0.150 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1455 | 0.150 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 2853 | 0.150 |
Why?
|
| Retrospective Studies | 1 | 2025 | 2544 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 154 | 0.140 |
Why?
|
| Risk Factors | 1 | 2025 | 3994 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 495 | 0.130 |
Why?
|
| Translations | 1 | 2016 | 7 | 0.130 |
Why?
|
| Ownership | 1 | 2016 | 12 | 0.120 |
Why?
|
| Geography | 1 | 2016 | 110 | 0.120 |
Why?
|
| Public Health | 1 | 2020 | 424 | 0.120 |
Why?
|
| Communication Barriers | 1 | 2016 | 60 | 0.120 |
Why?
|
| Trace Elements | 1 | 2016 | 35 | 0.120 |
Why?
|
| Hospitals | 1 | 2016 | 117 | 0.120 |
Why?
|
| Dust | 1 | 2016 | 57 | 0.120 |
Why?
|
| Mental Health | 1 | 2019 | 385 | 0.110 |
Why?
|
| Air Pollutants | 1 | 2016 | 130 | 0.110 |
Why?
|
| Soil | 1 | 2016 | 171 | 0.110 |
Why?
|
| Middle Aged | 2 | 2025 | 12222 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 749 | 0.090 |
Why?
|
| California | 2 | 2022 | 548 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2025 | 1869 | 0.070 |
Why?
|
| Adult | 1 | 2025 | 13872 | 0.070 |
Why?
|
| E2F1 Transcription Factor | 1 | 2025 | 22 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2025 | 35 | 0.060 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2025 | 12 | 0.060 |
Why?
|
| Electron Transport Complex II | 1 | 2025 | 6 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2025 | 51 | 0.060 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2025 | 64 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2024 | 32 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 63 | 0.050 |
Why?
|
| Methionine | 1 | 2024 | 27 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2026 | 144 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2025 | 149 | 0.050 |
Why?
|
| Choline | 1 | 2024 | 61 | 0.050 |
Why?
|
| Amino Acids | 1 | 2024 | 148 | 0.050 |
Why?
|
| Commerce | 1 | 2024 | 95 | 0.050 |
Why?
|
| Disease Progression | 1 | 2025 | 667 | 0.050 |
Why?
|
| Food | 1 | 2024 | 103 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 220 | 0.050 |
Why?
|
| Prognosis | 1 | 2024 | 861 | 0.050 |
Why?
|
| Workflow | 1 | 2021 | 26 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 704 | 0.040 |
Why?
|
| Hela Cells | 1 | 2022 | 376 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 126 | 0.040 |
Why?
|
| Social Class | 1 | 2022 | 291 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2020 | 13 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1766 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 2019 | 25 | 0.040 |
Why?
|
| Public Opinion | 1 | 2019 | 20 | 0.040 |
Why?
|
| Censuses | 1 | 2019 | 28 | 0.040 |
Why?
|
| Happiness | 1 | 2019 | 16 | 0.040 |
Why?
|
| Protein Structure, Quaternary | 1 | 2019 | 69 | 0.040 |
Why?
|
| Cisplatin | 1 | 2020 | 98 | 0.040 |
Why?
|
| Semantics | 1 | 2019 | 29 | 0.040 |
Why?
|
| Dictyostelium | 1 | 2019 | 45 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2022 | 549 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2019 | 142 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2019 | 199 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2019 | 191 | 0.030 |
Why?
|
| Rats | 1 | 2025 | 3735 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 590 | 0.030 |
Why?
|
| United States | 2 | 2019 | 5205 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 690 | 0.030 |
Why?
|
| Personal Health Services | 1 | 2016 | 2 | 0.030 |
Why?
|
| American Hospital Association | 1 | 2016 | 3 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 876 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2016 | 47 | 0.030 |
Why?
|
| Multilingualism | 1 | 2016 | 52 | 0.030 |
Why?
|
| Seasons | 1 | 2016 | 139 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 148 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2016 | 178 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 341 | 0.030 |
Why?
|